Audentes Therapeutics, Inc., a biotechnology company committed to the development and commercialization of gene therapy products for patients with serious, rare diseases, has announced the continued expansion of its leadership team, including the appointment of John T. Gray, Ph.D., as Vice President, Research and Development. Dr. Gray brings more than 20 years of gene therapy research and manufacturing experience to Audentes. In addition to Dr. Gray, Audentes has appointed Mary Newman as Senior Vice President, Regulatory Affairs and Dawn Blessing as Vice President, Corporate Development.
Help employers find you! Check out all the jobs and post your resume.
